Fredun Pharmaceuticals ke results ne market mein hungama macha diya hai. Company ka net profit seedha **96.9%** badhkar **₹18.57 Crore** ho gaya hai, aur ab ye NSE par list hone ki planning kar rahi hai.
Results mein dikhi dumdaar growth
Is baar Fredun Pharmaceuticals ne balance sheet mein aag laga di hai! September quarter mein company ka net profit 96.9% jump hokar ₹18.57 Crore par pahunch gaya hai, jo last year isi period mein sirf ₹9.43 Crore tha. Sirf profit hi nahi, revenue bhi 84.2% badhkar ₹267.64 Crore ho gaya hai. Auditor M/s. R.H. Nisar & Co. ne bhi clean chit de di hai, matlab financials solid hain.
Ab NSE par entry ki news
Sirf profit hi nahi, management ne ek aur bada faisla liya hai. Board ne shares ko NSE par list karne ki application ko manzoori de di hai. Iska seedha matlab ye hai ki stock ki liquidity badhegi aur zyada retail investors isme participate kar payenge. Ab bas regulator ke clearance ka wait hai. Jo log abhi is stock par nazar rakhna chahte hain, unhe NSE listing ki timeline par focus karna chahiye, kyunki wahi iska agla bada catalyst hoga.